Effects of the silencing of hypoxia-inducible factor-1 alpha on metastasis of pancreatic cancer

European Review for Medical and Pharmacological Sciences

Volumn 17, Issue 4, 2013, Pages 436-446

  Wei, H ^a   Li, F ^a   Fu, P ^a   Liu, X ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Metastasis; Pancreatic carcinoma; RNA interference; Tumor hypoxia

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1ALPHA; MESSENGER RNA; SMALL INTERFERING RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; HYPOXIA; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; MOUSE; NONHUMAN; PANCREAS CANCER; PLASMID; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; CELL CULTURE TECHNIQUES; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FLOW CYTOMETRY; GENE SILENCING; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; IN SITU NICK-END LABELING; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; PLASMIDS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84878564595     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. KASUYA K, TSUCHIDA A, NAGAKAWA Y, SUZUKI M, ABE Y, ITOI T, SERIZAWA H, NAGAO T, SHIMAZU M, AOKI T. Hypoxia- inducible factor-1α expression and gemcitabine chemotherapy for pancreatic cancer. Oncol Rep 2011; 26: 1399-1406.
2. BINDRA RS, CROSBY ME, GLAZER PM. Regulation of DNA repair in hypoxic cancer cells. Cancer Metast Rev 2007; 26: 249-260.
3. SEMENZA GL. Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 2010; 29: 625-634.
4. HASHIMOTO O, SHIMIZU K, SEMBA S, CHIBA S, KU Y, YOKOZAKI H, HORI Y. Hypoxia induces tumor aggressiveness and the expansion of CD133-posi tive cells in a hypoxia-inducible factor-1α- dependent manner in pancreatic cancer cells. Pathobiology 2011; 78: 181-192.
5. SEMENZA GL. Hypoxia-inducible factor 1 (HIF-1) pathway. Sci STKE 2007; 407: 8.
6. BERCHNER-PFANNSCHMIDT U, FREDE S, WOTZLAW C, FANDREY J. Imaging of the hypoxia-inducible factor pathway: insights into oxygen sensing. Eur Respir J 2008; 32: 210-217.
7. SEMENZA GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003; 3: 3721-3732.
8. REKWIROWICZ H, MARSZALEK A. Hypoxia inducible factor 1, a new possible important factor in neoplasia. Pol J Pathol 2009; 60: 61-66.
9. QING G, SIMON MC. Hypoxia inducible factor-2á: A critical mediator of aggressive tumor phenotypes. Curr Opin Genet Dev 2009; 19: 60-66.
10. SEMENZA GL. Hypoxia inducible factor 1 and cancer pathogenesis. IUBMB Life 2008; 60: 591-597.
11. LEE JW, BAE SH, JEONG JW, KIM SH, KIM KW. Hypoxia inducible factor (HIF1) [alpha]: its protein stability and biological functions. Exp Mol Med 2004; 36: 1-12.
12. HIDALGO M. Pancreatic cancer. N Engl J Med 2010; 362: 1605-1617.
13. MICHALSKI CW, ERKAN M, FRIESS H, KLEEFF J. Tumor metabolism to blood flow ratio in pancreatic cancer: helpful in patient stratification? Future Oncol 2010; 6: 13-15.
14. PENG XH, KARNA P, CAO Z, JIANG BH, ZHOU M, YANG L. Cross-talk between epidermal growth factor and hypoxia-inducible factor-1alpha signal pathways increases resistance to apoptosis by upregulating survivin gene expression. J Biol Chem 2006, 281: 25903-25914.
15. MCKENZIE JA, GROSSMAN D. Role of the apoptotic and mitotic regulator survivin in melanoma. Anticancer Res 2012; 32: 397-404.
16. MIZUNO T, NAGAO M, YAMADA Y, NARIKIYO M, UENO M, MIYAQISHI M, TAIRA K, NAKAJIMA Y. Small interfering RNA expression vector targeting hypoxia-inducible factor-1 alpha inhibits tumor growth in hepatobiliary and pancreatic cancers. Cancer Gene Ther 2006; 13: 131-140.
17. REY S, SEMENZA GL. Hypoxia-inducible factor-1- dependent mechanisms of vascularization and vascular remodeling. Cardiovascular Res 2010; 86: 236-242.
18. SHEN F, WALKER EJ, JIANG L, DEGOS V, LI J, SUN B, HERIYANTO F, YOUNG WL, SU H. Coexpression of angiopoietin- 1 with VEGF increases the structural integrity of the blood-brain barrier and reduces atrophy volume. J Cereb Blood Flow Metab. 2011, 31:2343-51.
19. SEMENZA GL. Hypoxia-inducible factor 1: regulator of mitochondrial metabolism and mediator of ischemic preconditioning. Biochim Biophys Acta 2011; 1813: 1263-1268.
20. DEBERARDINIS RJ, LUM JJ, HATZIVASSILIOU G, THOMPSON CB. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation. Cell Metab 2008; 7: 11-20.
21. BARTRONS R, CARO J. Hypoxia, glucose metabolism and the Warburg's effect. J Bioenerg Biomembr 2007; 39: 223-229.
22. SEMENZA GL. Regulation of cancer cell metabolism by hypoxia-inducible factor-1. Semin Cancer Biol 2009; 19: 12-16.
23. FULDA S, DEBATIN KM. HIF-1-regulated glucose metabolism: a key to apoptosis resistance? Cell Cycle 2007; 6: 790-792.
24. GRAHAM RM, FRAZIER DP, THOMPSON JW, HALIKO S, LI H, WASSERLAUF BJ, SPIGA MG, BISHOPRIC NH, WEBSTER KA. Aunique pathway of cardiac myocyte death caused by hypoxia-acidosis. J Exp Biol 2004; 207: 3189-3200.
25. KAROVIC O, TONAZZINI I, REBOLA N, EDSTROM E, LOVDAHL C, FREDHOLM BB, DARE E. Toxic effects of cobalt in primary culture of mouse astrocytes. Similarities with hypoxia and role of HIF-1alpha. Biochem Pharmacol 2007; 73: 694-708.
26. ALTIERI DC. Survivin, cancer networks and pathway- directed drug discovery. Nat Rev Cancer 2008; 8: 61-70.
27. KILIC M, KASPERCZYK H, FULDA S, DEBATIN KM. Role of hypoxia inducible factor-1 alpha in modulation of apoptosis resistance. Oncogene 2007; 26: 2027-2038.
28. BACH A, BENDER-SIGEL J, SCHRENK D, FLUGEL D, KIETZMANN T. The antioxidant quercetin inhibits cellular proliferation via HIF-1-dependent induction of p21WAF. Antioxid Redox Signal 2010; 13: 437-448.